data_1nlp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nlp _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.432 -0.581 . . . . 2.31 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' PHE . . . . . 0.533 ' HB3' ' CG2' ' C' ' 61' ' ' VAL . 3.0 m-85 -103.5 175.92 5.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 2.27 109.545 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' VAL . . . . . 0.456 ' O ' HG21 ' C' ' 61' ' ' VAL . 61.5 t -129.67 133.77 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 1.36 109.196 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' ALA . . . . . 0.577 ' HB2' ' CD1' ' C' ' 26' ' ' PHE . . . -79.18 93.85 5.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.066 -1.021 . . . . 1.12 109.969 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' LEU . . . . . 0.591 ' O ' ' CD1' ' C' ' 14' ' ' TYR . 99.8 mt -38.76 -31.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.655 -0.653 . . . . 1.34 109.639 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' TYR . . . . . 0.661 ' CE2' HD21 ' N' ' 79' ' ' LEU . 10.1 m-85 -151.63 163.58 38.78 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.358 -0.937 . . . . 2.35 110.463 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ASP . . . . . 0.497 ' CB ' ' HA ' ' C' ' 27' ' ' LYS . 2.1 m-20 -66.04 120.14 12.62 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.245 -1.02 . . . . 1.91 108.245 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' TYR . . . . . 0.661 ' CB ' ' CZ ' ' C' ' 26' ' ' PHE . 17.5 t80 -96.89 123.71 40.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.947 -1.096 . . . . 1.93 110.103 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . 0.454 ' HA ' ' HB3' ' C' ' 25' ' ' SER . 3.4 pt-20 -95.41 93.87 7.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.645 -0.659 . . . . 2.73 109.261 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.38 158.91 19.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 1.74 109.91 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -125.43 -18.81 5.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 4.81 109.866 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' THR . . . . . 0.425 ' OG1' ' N ' ' C' ' 21' ' ' GLU . 0.1 OUTLIER -106.78 175.28 5.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.072 -1.017 . . . . 1.55 109.532 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' GLU . . . . . 0.425 ' N ' ' OG1' ' C' ' 20' ' ' THR . 12.8 mt-10 -89.23 12.43 16.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 4.0 109.801 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.98 -46.08 5.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.003 . . . . 1.43 109.58 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' ASP . . . . . 0.603 ' HA ' ' N ' ' C' ' 55' ' ' TYR . 0.7 OUTLIER -94.94 149.98 20.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.232 -0.918 . . . . 2.0 110.388 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' LEU . . . . . 0.47 HD13 ' O ' ' C' ' 53' ' ' THR . 19.2 mt -103.51 158.95 16.0 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.97 -0.752 . . . . 2.27 108.97 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' C' ' 16' ' ' TYR . 0.0 OUTLIER -96.9 134.69 39.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.23 -0.919 . . . . 0.84 109.057 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.661 ' CZ ' ' CB ' ' C' ' 16' ' ' TYR . 3.8 p90 -122.16 -177.74 3.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.969 -1.082 . . . . 2.21 109.976 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LYS . . . . . 0.497 ' HA ' ' CB ' ' C' ' 15' ' ' ASP . 14.6 mttt -118.41 171.64 8.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.449 -0.782 . . . . 3.69 109.793 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -74.11 124.78 26.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 3.19 109.412 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.63 -9.95 68.8 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.411 -1.475 . . . . 0.65 109.411 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -70.05 145.07 51.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -1.17 . . . . 1.87 109.38 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -101.67 135.8 42.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 4.26 109.455 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' LEU . . . . . 0.41 ' HB3' ' HB2' ' C' ' 45' ' ' ALA . 2.0 mp -133.83 132.78 40.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 1.5 109.463 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.73 117.76 16.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 2.99 109.374 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 24.8 mm -72.84 140.47 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 1.33 109.685 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' C' ' 44' ' ' LEU . 25.4 t -113.38 -74.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 1.23 109.352 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -113.08 115.59 28.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.359 -0.838 . . . . 2.33 109.098 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' ASN . . . . . 0.587 ' HA ' ' CD1' ' C' ' 43' ' ' TRP . 41.5 p30 -128.15 45.05 2.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 2.55 109.682 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 12.5 t -132.3 13.16 4.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 1.86 109.415 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.06 -52.8 4.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 4.51 109.467 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.36 -132.81 1.53 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.555 -1.418 . . . . 1.3 109.555 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -90.19 15.94 9.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -1.126 . . . . 1.51 109.559 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -134.33 120.56 20.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.51 109.727 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' TRP . . . . . 0.587 ' CD1' ' HA ' ' C' ' 37' ' ' ASN . 6.5 m0 -114.54 157.18 23.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.788 . . . . 0.5 109.35 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.576 HD11 ' CD1' ' C' ' 55' ' ' TYR . 33.4 tp -91.06 111.4 22.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 1.53 109.16 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ALA . . . . . 0.437 ' HB3' HG12 ' C' ' 56' ' ' ILE . . . -100.69 170.69 8.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.059 -1.026 . . . . 1.24 110.041 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -136.78 111.38 8.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.419 -0.801 . . . . 1.32 109.1 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 68.5 m -66.47 127.13 31.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 1.47 109.592 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 mt -90.0 -10.28 45.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 2.15 109.418 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.0 m -63.72 -59.84 4.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 2.98 109.396 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' THR . . . . . 0.404 ' CG2' ' N ' ' C' ' 51' ' ' GLY . 10.3 t -101.01 -41.6 6.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 2.99 109.444 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' GLY . . . . . 0.404 ' N ' ' CG2' ' C' ' 50' ' ' THR . . . 114.53 54.44 0.4 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.603 -1.399 . . . . 1.91 109.603 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -126.56 169.85 12.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 3.52 109.341 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' THR . . . . . 0.537 ' CG2' HD13 ' C' ' 44' ' ' LEU . 6.2 m -123.37 148.38 46.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.934 . . . . 1.39 109.62 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' GLY . . . . . 0.463 ' HA3' ' HG ' ' C' ' 24' ' ' LEU . . . -174.9 129.02 1.5 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.657 -1.377 . . . . 0.5 109.657 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' TYR . . . . . 0.603 ' N ' ' HA ' ' C' ' 23' ' ' ASP . 9.4 m-85 -50.15 174.75 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.354 -1.086 . . . . 2.5 109.513 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.437 HG12 ' HB3' ' C' ' 45' ' ' ALA . 0.9 OUTLIER -158.3 144.06 12.39 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.841 -0.799 . . . . 1.56 108.841 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' PRO . . . . . 0.596 ' HG3' ' CD1' ' C' ' 16' ' ' TYR . 31.5 Cg_endo -74.4 122.56 7.56 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.266 1.977 . . . . 0.24 110.063 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' SER . . . . . 0.577 ' HB2' ' CZ2' ' C' ' 43' ' ' TRP . 2.0 p -61.62 -27.59 68.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.609 -0.682 . . . . 0.88 111.473 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' ASN . . . . . 0.505 ' OD1' ' HB2' ' C' ' 57' ' ' PRO . 34.3 p-10 -71.8 -22.06 61.62 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.771 -1.206 . . . . 0.47 110.323 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' TYR . . . . . 0.588 ' CE1' ' HA ' ' N' ' 79' ' ' LEU . 3.5 m-85 -96.75 0.98 50.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.044 -1.035 . . . . 2.06 109.505 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . 0.549 ' CG1' ' HA ' ' C' ' 58' ' ' SER . 4.5 p -127.43 167.58 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.493 -0.755 . . . . 1.25 109.619 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' ALA . . . . . 0.525 ' N ' ' CG2' ' C' ' 61' ' ' VAL . . . -151.75 151.04 27.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.549 -0.719 . . . . 1.29 109.42 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.98 115.9 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.62 2.214 . . . . 0.9 110.454 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.998 -1.001 . . . . 3.01 109.468 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' N' N ' 72' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.761 . . . . . . . . 1.52 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' N' N ' 73' ' ' MN8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' N' N ' 74' ' ' MN1 . . . . . 0.489 ' H51' ' HD3' ' N' ' 75' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' N' N ' 75' ' ' PRO . . . . . 0.489 ' HD3' ' H51' ' N' ' 74' ' ' MN1 . 36.3 Cg_endo -78.49 140.38 16.98 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.603 2.202 . . . . 0.87 110.415 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 76' ' ' LEU . . . . . 0.468 ' HB3' ' HD2' ' N' ' 77' ' ' PRO . 4.7 mt -73.04 160.22 83.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 1.26 109.479 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 77' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' N' ' 76' ' ' LEU . 35.2 Cg_endo -77.41 167.06 25.1 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.558 2.172 . . . . 0.54 110.413 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 78' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' N' ' 79' ' ' LEU . 35.8 Cg_endo -78.27 97.33 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.582 2.188 . . . . 0.79 110.674 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 79' ' ' LEU . . . . . 0.661 HD21 ' CE2' ' C' ' 14' ' ' TYR . 9.9 mt -43.0 150.85 0.43 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 1.4 109.367 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 80' ' ' PRO . . . . . 0.62 ' HG2' ' CD1' ' C' ' 14' ' ' TYR . 36.5 Cg_endo -76.81 -46.24 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.817 2.345 . . . . 1.29 110.51 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' N' N ' 81' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 119.816 -1.803 . . . . 2.11 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.432 -0.581 . . . . 1.77 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 10' ' ' PHE . . . . . 0.548 ' HB3' ' CG2' ' C' ' 61' ' ' VAL . 3.0 m-85 -103.5 175.92 5.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 1.37 109.545 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.67 133.77 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 0.58 109.196 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' ALA . . . . . 0.718 ' HB1' ' CD1' ' C' ' 26' ' ' PHE . . . -79.18 93.85 5.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.066 -1.021 . . . . 0.36 109.969 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' LEU . . . . . 0.602 ' HB3' ' CE2' ' C' ' 14' ' ' TYR . 99.8 mt -38.76 -31.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.655 -0.653 . . . . 0.67 109.639 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' TYR . . . . . 0.688 ' CE2' HD22 ' N' ' 79' ' ' LEU . 10.1 m-85 -151.63 163.58 38.78 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.358 -0.937 . . . . 1.45 110.463 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' C' ' 27' ' ' LYS . 2.1 m-20 -66.04 120.14 12.62 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.245 -1.02 . . . . 1.91 108.245 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' TYR . . . . . 0.661 ' CB ' ' CZ ' ' C' ' 26' ' ' PHE . 17.5 t80 -96.89 123.71 40.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.947 -1.096 . . . . 1.14 110.103 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 17' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' C' ' 25' ' ' SER . 3.4 pt-20 -95.41 93.87 7.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.645 -0.659 . . . . 2.73 109.261 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.38 158.91 19.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 1.44 109.91 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -125.43 -18.81 5.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 4.22 109.866 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' THR . . . . . 0.425 ' OG1' ' N ' ' C' ' 21' ' ' GLU . 0.1 OUTLIER -106.78 175.28 5.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.072 -1.017 . . . . 1.2 109.532 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 21' ' ' GLU . . . . . 0.425 ' N ' ' OG1' ' C' ' 20' ' ' THR . 12.8 mt-10 -89.23 12.43 16.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 4.0 109.801 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.98 -46.08 5.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.003 . . . . 1.2 109.58 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' ASP . . . . . 0.617 ' HA ' ' N ' ' C' ' 55' ' ' TYR . 0.7 OUTLIER -94.94 149.98 20.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.232 -0.918 . . . . 2.0 110.388 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 24' ' ' LEU . . . . . 0.503 HD12 ' C ' ' C' ' 53' ' ' THR . 19.2 mt -103.51 158.95 16.0 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.97 -0.752 . . . . 1.65 108.97 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' C' ' 16' ' ' TYR . 0.0 OUTLIER -96.9 134.69 39.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.23 -0.919 . . . . 0.44 109.057 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 0.718 ' CD1' ' HB1' ' C' ' 12' ' ' ALA . 3.8 p90 -122.16 -177.74 3.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.969 -1.082 . . . . 1.3 109.976 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' C' ' 15' ' ' ASP . 14.6 mttt -118.41 171.64 8.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.449 -0.782 . . . . 3.15 109.793 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' C' ' 13' ' ' LEU . 3.4 tttt -74.11 124.78 26.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 2.81 109.412 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.63 -9.95 68.8 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.411 -1.475 . . . . 0.6 109.411 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -70.05 145.07 51.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -1.17 . . . . 1.87 109.38 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -101.67 135.8 42.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 3.62 109.455 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' LEU . . . . . 0.436 ' HB3' ' HB1' ' C' ' 45' ' ' ALA . 2.0 mp -133.83 132.78 40.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.88 109.463 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -74.73 117.76 16.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 2.38 109.374 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' C' ' 34' ' ' ILE . 24.8 mm -72.84 140.47 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.61 109.685 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' C' ' 44' ' ' LEU . 25.4 t -113.38 -74.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.51 109.352 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -113.08 115.59 28.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.359 -0.838 . . . . 1.86 109.098 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' ASN . . . . . 0.595 ' HA ' ' CD1' ' C' ' 43' ' ' TRP . 41.5 p30 -128.15 45.05 2.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 1.97 109.682 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 12.5 t -132.3 13.16 4.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 1.86 109.415 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.06 -52.8 4.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 4.51 109.467 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.36 -132.81 1.53 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.555 -1.418 . . . . 0.85 109.555 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' ASP . . . . . 0.666 ' HB3' HD11 ' N' ' 76' ' ' LEU . 2.9 m-20 -90.19 15.94 9.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -1.126 . . . . 1.51 109.559 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 42' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -134.33 120.56 20.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.4 109.727 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' TRP . . . . . 0.605 ' CZ2' ' HB2' ' C' ' 58' ' ' SER . 6.5 m0 -114.54 157.18 23.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.788 . . . . 0.44 109.35 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.8 HD13 ' CE1' ' C' ' 55' ' ' TYR . 33.4 tp -91.06 111.4 22.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.87 109.16 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ALA . . . . . 0.507 ' HB2' HG12 ' C' ' 56' ' ' ILE . . . -100.69 170.69 8.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.059 -1.026 . . . . 0.5 110.041 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -136.78 111.38 8.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.419 -0.801 . . . . 1.06 109.1 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 68.5 m -66.47 127.13 31.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 1.1 109.592 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 mt -90.0 -10.28 45.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 1.75 109.418 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.0 m -63.72 -59.84 4.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 2.48 109.396 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' THR . . . . . 0.519 HG23 ' N ' ' C' ' 51' ' ' GLY . 10.3 t -101.01 -41.6 6.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 2.59 109.444 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 51' ' ' GLY . . . . . 0.519 ' N ' HG23 ' C' ' 50' ' ' THR . . . 114.53 54.44 0.4 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.603 -1.399 . . . . 1.91 109.603 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -126.56 169.85 12.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 2.88 109.341 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' THR . . . . . 0.551 HG22 HD11 ' C' ' 44' ' ' LEU . 6.2 m -123.37 148.38 46.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.934 . . . . 0.95 109.62 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' GLY . . . . . 0.486 ' HA3' ' HG ' ' C' ' 24' ' ' LEU . . . -174.9 129.02 1.5 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.657 -1.377 . . . . 0.4 109.657 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 55' ' ' TYR . . . . . 0.8 ' CE1' HD13 ' C' ' 44' ' ' LEU . 9.4 m-85 -50.15 174.75 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.354 -1.086 . . . . 1.61 109.513 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.548 HG23 ' O ' ' C' ' 55' ' ' TYR . 0.9 OUTLIER -158.3 144.06 12.39 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.841 -0.799 . . . . 0.88 108.841 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 57' ' ' PRO . . . . . 0.624 ' HG3' ' CD1' ' C' ' 16' ' ' TYR . 31.5 Cg_endo -74.4 122.56 7.56 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.266 1.977 . . . . 0.22 110.063 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 58' ' ' SER . . . . . 0.605 ' HB2' ' CZ2' ' C' ' 43' ' ' TRP . 2.0 p -61.62 -27.59 68.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.609 -0.682 . . . . 0.67 111.473 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' ASN . . . . . 0.516 ' OD1' ' HB2' ' C' ' 57' ' ' PRO . 34.3 p-10 -71.8 -22.06 61.62 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.771 -1.206 . . . . 0.39 110.323 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 60' ' ' TYR . . . . . 0.595 ' CE1' ' HA ' ' N' ' 79' ' ' LEU . 3.5 m-85 -96.75 0.98 50.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.044 -1.035 . . . . 1.22 109.505 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 61' ' ' VAL . . . . . 0.64 HG22 ' N ' ' C' ' 62' ' ' ALA . 4.5 p -127.43 167.58 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.493 -0.755 . . . . 0.5 109.619 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' ALA . . . . . 0.64 ' N ' HG22 ' C' ' 61' ' ' VAL . . . -151.75 151.04 27.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.549 -0.719 . . . . 0.59 109.42 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.98 115.9 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.62 2.214 . . . . 0.9 110.454 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.998 -1.001 . . . . 2.5 109.468 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' N' N ' 72' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.761 . . . . . . . . 1.03 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' N' N ' 73' ' ' MN8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' N' N ' 74' ' ' MN1 . . . . . 0.486 ' H52' ' HD3' ' N' ' 75' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' N' N ' 75' ' ' PRO . . . . . 0.486 ' HD3' ' H52' ' N' ' 74' ' ' MN1 . 36.3 Cg_endo -78.49 140.38 16.98 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.603 2.202 . . . . 0.76 110.415 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 76' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' C' ' 41' ' ' ASP . 4.7 mt -73.04 160.22 83.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.61 109.479 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 77' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' N' ' 76' ' ' LEU . 35.2 Cg_endo -77.41 167.06 25.1 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.558 2.172 . . . . 0.5 110.413 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 78' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' N' ' 79' ' ' LEU . 35.8 Cg_endo -78.27 97.33 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.582 2.188 . . . . 0.69 110.674 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 79' ' ' LEU . . . . . 0.688 HD22 ' CE2' ' C' ' 14' ' ' TYR . 9.9 mt -43.0 150.85 0.43 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.84 109.367 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 80' ' ' PRO . . . . . 0.656 ' HG2' ' CD1' ' C' ' 14' ' ' TYR . 36.5 Cg_endo -76.81 -46.24 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.817 2.345 . . . . 1.29 110.51 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' N' N ' 81' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 119.816 -1.803 . . . . 1.43 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.432 -0.581 . . . . 1.77 109.432 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' PHE . . . . . 0.548 ' HB3' ' CG2' ' C' ' 61' ' ' VAL . 3.0 m-85 -103.5 175.92 5.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 1.37 109.545 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' VAL . . . . . . . . . . . . . 61.5 t -129.67 133.77 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.366 -0.834 . . . . 0.58 109.196 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' ALA . . . . . 0.718 ' HB1' ' CD1' ' C' ' 26' ' ' PHE . . . -79.18 93.85 5.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.066 -1.021 . . . . 0.36 109.969 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' LEU . . . . . 0.602 ' HB3' ' CE2' ' C' ' 14' ' ' TYR . 99.8 mt -38.76 -31.34 0.06 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.655 -0.653 . . . . 0.67 109.639 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' TYR . . . . . 0.688 ' CE2' HD22 ' N' ' 79' ' ' LEU . 10.1 m-85 -151.63 163.58 38.78 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.358 -0.937 . . . . 1.45 110.463 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' C' ' 27' ' ' LYS . 2.1 m-20 -66.04 120.14 12.62 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.245 -1.02 . . . . 1.91 108.245 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' TYR . . . . . 0.661 ' CB ' ' CZ ' ' C' ' 26' ' ' PHE . 17.5 t80 -96.89 123.71 40.67 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.947 -1.096 . . . . 1.14 110.103 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' C' ' 25' ' ' SER . 3.4 pt-20 -95.41 93.87 7.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.645 -0.659 . . . . 2.73 109.261 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.38 158.91 19.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 1.44 109.91 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' ARG . . . . . . . . . . . . . 7.0 mtt-85 -125.43 -18.81 5.2 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 4.22 109.866 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' THR . . . . . 0.425 ' OG1' ' N ' ' C' ' 21' ' ' GLU . 0.1 OUTLIER -106.78 175.28 5.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.072 -1.017 . . . . 1.2 109.532 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' GLU . . . . . 0.425 ' N ' ' OG1' ' C' ' 20' ' ' THR . 12.8 mt-10 -89.23 12.43 16.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.258 -0.901 . . . . 4.0 109.801 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.98 -46.08 5.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.094 -1.003 . . . . 1.2 109.58 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' ASP . . . . . 0.617 ' HA ' ' N ' ' C' ' 55' ' ' TYR . 0.7 OUTLIER -94.94 149.98 20.66 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.232 -0.918 . . . . 2.0 110.388 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' LEU . . . . . 0.503 HD12 ' C ' ' C' ' 53' ' ' THR . 19.2 mt -103.51 158.95 16.0 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.97 -0.752 . . . . 1.65 108.97 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' C' ' 16' ' ' TYR . 0.0 OUTLIER -96.9 134.69 39.91 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.23 -0.919 . . . . 0.44 109.057 179.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 0.718 ' CD1' ' HB1' ' C' ' 12' ' ' ALA . 3.8 p90 -122.16 -177.74 3.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.969 -1.082 . . . . 1.3 109.976 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' C' ' 15' ' ' ASP . 14.6 mttt -118.41 171.64 8.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.449 -0.782 . . . . 3.15 109.793 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' C' ' 13' ' ' LEU . 3.4 tttt -74.11 124.78 26.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 2.81 109.412 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.63 -9.95 68.8 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.411 -1.475 . . . . 0.6 109.411 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' GLU . . . . . . . . . . . . . 13.2 tt0 -70.05 145.07 51.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.211 -1.17 . . . . 1.87 109.38 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -101.67 135.8 42.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 3.62 109.455 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' LEU . . . . . 0.436 ' HB3' ' HB1' ' C' ' 45' ' ' ALA . 2.0 mp -133.83 132.78 40.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.88 109.463 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.73 117.76 16.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.923 . . . . 2.38 109.374 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . 0.445 HD13 ' HA ' ' C' ' 34' ' ' ILE . 24.8 mm -72.84 140.47 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.234 -0.916 . . . . 0.61 109.685 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' C' ' 44' ' ' LEU . 25.4 t -113.38 -74.78 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.273 -0.892 . . . . 0.51 109.352 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -113.08 115.59 28.56 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.359 -0.838 . . . . 1.86 109.098 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' ASN . . . . . 0.595 ' HA ' ' CD1' ' C' ' 43' ' ' TRP . 41.5 p30 -128.15 45.05 2.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -0.837 . . . . 1.97 109.682 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' THR . . . . . . . . . . . . . 12.5 t -132.3 13.16 4.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 1.86 109.415 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -90.06 -52.8 4.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.211 -0.931 . . . . 4.51 109.467 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.36 -132.81 1.53 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.555 -1.418 . . . . 0.85 109.555 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' ASP . . . . . 0.666 ' HB3' HD11 ' N' ' 76' ' ' LEU . 2.9 m-20 -90.19 15.94 9.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.285 -1.126 . . . . 1.51 109.559 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -134.33 120.56 20.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.156 -0.965 . . . . 0.4 109.727 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' TRP . . . . . 0.605 ' CZ2' ' HB2' ' C' ' 58' ' ' SER . 6.5 m0 -114.54 157.18 23.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.44 -0.788 . . . . 0.44 109.35 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.8 HD13 ' CE1' ' C' ' 55' ' ' TYR . 33.4 tp -91.06 111.4 22.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.161 -0.962 . . . . 0.87 109.16 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ALA . . . . . 0.507 ' HB2' HG12 ' C' ' 56' ' ' ILE . . . -100.69 170.69 8.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.059 -1.026 . . . . 0.5 110.041 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' HIS . . . . . . . . . . . . . 59.5 t60 -136.78 111.38 8.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.419 -0.801 . . . . 1.06 109.1 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 68.5 m -66.47 127.13 31.12 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 1.1 109.592 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' LEU . . . . . . . . . . . . . 22.9 mt -90.0 -10.28 45.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.913 . . . . 1.75 109.418 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' THR . . . . . . . . . . . . . 7.0 m -63.72 -59.84 4.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 2.48 109.396 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' THR . . . . . 0.519 HG23 ' N ' ' C' ' 51' ' ' GLY . 10.3 t -101.01 -41.6 6.73 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.214 -0.929 . . . . 2.59 109.444 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' GLY . . . . . 0.519 ' N ' HG23 ' C' ' 50' ' ' THR . . . 114.53 54.44 0.4 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.603 -1.399 . . . . 1.91 109.603 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -126.56 169.85 12.64 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.296 -1.12 . . . . 2.88 109.341 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' THR . . . . . 0.551 HG22 HD11 ' C' ' 44' ' ' LEU . 6.2 m -123.37 148.38 46.11 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.206 -0.934 . . . . 0.95 109.62 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' GLY . . . . . 0.486 ' HA3' ' HG ' ' C' ' 24' ' ' LEU . . . -174.9 129.02 1.5 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.657 -1.377 . . . . 0.4 109.657 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' TYR . . . . . 0.8 ' CE1' HD13 ' C' ' 44' ' ' LEU . 9.4 m-85 -50.15 174.75 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.354 -1.086 . . . . 1.61 109.513 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.548 HG23 ' O ' ' C' ' 55' ' ' TYR . 0.9 OUTLIER -158.3 144.06 12.39 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.841 -0.799 . . . . 0.88 108.841 -179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' PRO . . . . . 0.624 ' HG3' ' CD1' ' C' ' 16' ' ' TYR . 31.5 Cg_endo -74.4 122.56 7.56 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.266 1.977 . . . . 0.22 110.063 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' SER . . . . . 0.605 ' HB2' ' CZ2' ' C' ' 43' ' ' TRP . 2.0 p -61.62 -27.59 68.77 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.609 -0.682 . . . . 0.67 111.473 -178.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' ASN . . . . . 0.516 ' OD1' ' HB2' ' C' ' 57' ' ' PRO . 34.3 p-10 -71.8 -22.06 61.62 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.771 -1.206 . . . . 0.39 110.323 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' TYR . . . . . 0.595 ' CE1' ' HA ' ' N' ' 79' ' ' LEU . 3.5 m-85 -96.75 0.98 50.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.044 -1.035 . . . . 1.22 109.505 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . 0.64 HG22 ' N ' ' C' ' 62' ' ' ALA . 4.5 p -127.43 167.58 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.493 -0.755 . . . . 0.5 109.619 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' ALA . . . . . 0.64 ' N ' HG22 ' C' ' 61' ' ' VAL . . . -151.75 151.04 27.66 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.549 -0.719 . . . . 0.59 109.42 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.98 115.9 3.87 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.62 2.214 . . . . 0.9 110.454 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.998 -1.001 . . . . 2.5 109.468 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' N' N ' 72' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.761 . . . . . . . . 1.03 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' N' N ' 73' ' ' MN8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' N' N ' 74' ' ' MN1 . . . . . 0.486 ' H52' ' HD3' ' N' ' 75' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' N' N ' 75' ' ' PRO . . . . . 0.486 ' HD3' ' H52' ' N' ' 74' ' ' MN1 . 36.3 Cg_endo -78.49 140.38 16.98 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.603 2.202 . . . . 0.76 110.415 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 76' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' C' ' 41' ' ' ASP . 4.7 mt -73.04 160.22 83.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.23 -0.919 . . . . 0.61 109.479 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 77' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' N' ' 76' ' ' LEU . 35.2 Cg_endo -77.41 167.06 25.1 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.558 2.172 . . . . 0.5 110.413 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 78' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' N' ' 79' ' ' LEU . 35.8 Cg_endo -78.27 97.33 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.582 2.188 . . . . 0.69 110.674 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 79' ' ' LEU . . . . . 0.688 HD22 ' CE2' ' C' ' 14' ' ' TYR . 9.9 mt -43.0 150.85 0.43 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.282 -0.886 . . . . 0.84 109.367 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 80' ' ' PRO . . . . . 0.656 ' HG2' ' CD1' ' C' ' 14' ' ' TYR . 36.5 Cg_endo -76.81 -46.24 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.817 2.345 . . . . 1.29 110.51 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' N' N ' 81' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.363 0 O-C-N 119.816 -1.803 . . . . 1.43 . . . . . . . . . . 0 0 . 1 stop_ save_